Title |
Digoxin and mortality in atrial fibrillation: a prospective cohort study
|
---|---|
Published in |
European Journal of Clinical Pharmacology, August 2007
|
DOI | 10.1007/s00228-007-0346-9 |
Pubmed ID | |
Authors |
Pär Hallberg, Johan Lindbäck, Bertil Lindahl, Ulf Stenestrand, Håkan Melhus, for the RIKS-HIA group |
Abstract |
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study showed that rhythm-control treatment of patients with atrial fibrillation (AF) offered no survival advantage over a rate-control strategy. In a subgroup analysis of that study, it was found that digoxin increased the death rate [relative risk (RR) = 1.42), but it was suggested that this may have been attributable to prescription of digoxin for patients at greater risk of death, such as those with congestive heart failure (CHF). No study has investigated a priori the effect of digoxin on mortality in patients with AF. This study aimed to address this question. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
United States | 1 | 1% |
Denmark | 1 | 1% |
Unknown | 93 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 17% |
Student > Bachelor | 14 | 15% |
Student > Ph. D. Student | 13 | 14% |
Student > Master | 10 | 10% |
Other | 9 | 9% |
Other | 17 | 18% |
Unknown | 17 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 57 | 59% |
Agricultural and Biological Sciences | 5 | 5% |
Mathematics | 3 | 3% |
Chemistry | 3 | 3% |
Nursing and Health Professions | 2 | 2% |
Other | 8 | 8% |
Unknown | 18 | 19% |